Login to Your Account

Financings Roundup

Arena Back on Track with a $33M Equity Financing

By Catherine Shaffer
BioWorld Today Contributing Writer

Thursday, January 12, 2012

Just one day after resubmission of its new drug application for lorcaserin, Arena Pharmaceuticals Inc. is selling nearly 10 million shares of common stock to raise $33 million, demonstrating that it is moving forward following the October 2010 complete response letter from the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription